ICP DAS - BMP (Biomedical Polymers), a Taiwan medical TPU (thermoplastic polyurethane) supplier, will exhibit TPU pellets with 50% tungsten content (W50) for the first time in the COMPAMED 2022, Germany. The exhibition - a melting pot for high-tech solutions in the medical technology sector - takes place in DÜSSELDORF from 14 to 17 November. ICP DAS - BMP will showcase three series of highly stable medical-grade TPU pellets, namely, Alithane(TM)(ALP series), Durathane(TM)(ALC series), and Arothane(TM)(ARP series). This year, ICP DAS - BMP unveils a new range of pellets with a tungsten content of 30% (W30) and 50% (W50), respectively. As we advance, ICP DAS - BMP plans to develop pellets with 70% tungsten content (W70) and a new ARP-CHDM series in 2023. All medical-grade TPU pellets by ICP DAS - BMP are 100% made in Taiwan and have superb biocompatibility, hydrolytic & chemical resistance, mechanical properties, and radiodensity; they can be customized and color-matched. To provide customers with the best service, ICP DAS - BMP offers shorter lead times and accepts smaller quantity orders. Applications of medical-grade TPU pellets range from cancer treatment and urology devices to retainers, etc. Shortly after being established, ICP DAS - BMP achieves outstanding results domestically and internationally. Medical device manufacturers from South Korea, Israel, and France have chosen ICP DAS - BMP's trustworthy and high-quality TPUs. Visit ICP DAS - BMP's booth at Hall 08B, Booth 8BC17-2, from 14 to 17 November 2022, and learn more about the upcoming ARP-CHDM series. About ICP DAS - BMP In response to the growing demand for TPUs in medical applications, in 2018, ICP DAS established a new business unit to develop and produce medical-grade TPUs, ICP DAS - BMP. The company has obtained ISO 13485 certification for its raw material warehouses and production lines. ICP DAS - BMP has its own laboratories for polymerization, physical properties analysis, and cytotoxicity testing. All the TPUs supplied by ICP DAS - BMP are USP Class VI certified and compliant with the ISO 10993 international standard. Materials have passed skin sensitization and cytotoxicity tests according to ISO 10993-5 and ISO 10993-10. These enable ICP DAS - BMP to guarantee biocompatibility for medical device manufacturers. For more details, please visit our website: https://bmp.icpdas.com/ For TPU products, solutions, and inquiries, contact us directly: sales_bmp@icpdas.com Source:ICP DAS Co., Ltd. Image Attachments Links: Link: https://iop.asianetnews.net/view-attachment?attach-id=432804 Caption: ICP DAS - BMP to partake in the COMPAMED 2022, Germany